Skip to main content
. 2016 Nov 29;2016:1951707. doi: 10.1155/2016/1951707

Table 3.

Demographics, admission diagnosis, and characteristics of the patients according to survival status (n = 28).

Variable Survivors (n = 18) Nonsurvivors (n = 10) p
Age, (range) yrs 65.0 ± 2.5 71.6 ± 3.2 0.88
Males, n, % 10/18, 55.5% 6/10, 60.0% 1.0
Admission diagnosis, n
 Pulmonary Infection, RR 10 5
 Pulmonary edema, CHF 3 2
 Complicated surgery 2 2
 SAH/ICH 1 1
 Abdominal sepsis 1
 Trauma, head injury 1
Type, n
 Medical 16 8
 Surgical 2 2
APACHE II 21.9 ± 1.2 22.7 ± 1.5 0.58
SAPS II 62.9 ± 2.5 60.1 ± 3.5 0.83
SOFA 9.9 ± 0.9 10.5 ± 0.9 0.65
MV duration, days 14.3 ± 2.8 42.8 ± 11.7 0.039
ICU LOS (median), d 18.6 ± 2.9 (13) 55.0 ± 12.1 (51.5) 0.01
Fever, >38.2°C 8/18, 44,4% 4/10, 40% 1.0
Corrected calcium, mg/dL 7.9 ± 0.2 8.5 ± 0.6 0.65
Phosphorus, mg/dL 3.2 ± 0.3 3.8 ± 0.3 0.13
Alkaline phosphatase, mg/dL 117.7 ± 19.5 124.0 ± 17.1 0.18
Urea, mg/dL 54.5 ± 7.1 52.8 ± 8.3 0.96
AST (SGOT), IU/dL 51.4 ± 14.9 31.8 ± 4.6 1.0
ALT (SGPT), IU/dL 90.1 ± 44.4 31.1 ± 5.9 0.98
WBC, /mm3 10,964 ± 1,997 11,309 ± 1,804 0.79
Creatinine, mg/dL 1.1 ± 0.8 1.2 ± 0.2 0.51
Albumin, g/dL 3.0 ± 0.1 3.3 ± 0.2 0.38
CRP, mg/dL 112.1 ± 24.2 97.8 ± 38.9 0.75
i-CTx (ng/mL) 0,96 ± 0,19 1,49 ± 0,32 0.098
P1NP (ng/mL) 15,46 ± 2,44 19,85 ± 5,34 0.773
i-PTH (pg/mL) 215,9 ± 39,68 159,6 ± 32,68 0.533
25-OH Vit. D (ng/mL) 6,45 ± 1,49 3,80 ± 0,94 0.433
Low-dose steroids, n 12/18 4/10
Shock, nor-adrenaline, n 17/18 10/10
LMWH, n 14/18 5/10
Fondaparinux (Arixtra), n 4/18 5/10
Transfusions, n, (mean) 10/18 8/10
Phenytoin (Epanutin), n 2/18 1/10
Food supplementation, n 18/18 10/10
 Enteral 18/18 10/10
 Parenteral 1/18 1/10
 Both 1/18 1/10
 Micronutrients 18/18 10/10
 Vitamins 18/18 10/10

RR: respiratory failure, ICH: intracerebral hemorrhage, SAH: subarachnoid hemorrhage, CHF: congestive heart failure, LMWH: low molecular weight heparin, CRP: c-reactive protein, ICU: intensive care medicine, WBC: white blood cell, APACHE II: Acute Physiology And Chronic Health Evaluation, SOFA: Sequential Organ Failure Assessment, AST: Aspartate Aminotransferase, and ALT: Alanine Aminotransferase.